U
University Eye Specialists | Clinical Research Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Timolol Maleate
Latanoprost
Netarsudil
AR-15512
H-1337
STN1013600
Bimatoprost
AR-17043
DE-126
PG043
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
4 of 13 total trials
A Randomized Clinical Trial of Ab Interno Canaloplasty and Trabeculotomy with the OMNI® Surgical System Compared to Standard Medical Treatment in Pse...
Not yet enrolling
Primary Open Angle Glaucoma
Device: OMNI Surgical System
Drug: Latanoprost plus adjunctive glaucoma medication
The purpose of this two-stage clinical trial is to assess the safety and hypotensive efficacy of AR-17043 and PG043 ophthalmic solutions in subjects...
Begins enrollment in 1 month
Open Angle Glaucoma
Ocular Hypertension
Drug: AR-17043 Ophthalmic Solution
Drug: Netarsudil 0.02%/Latanoprost 0.005% Ophthalmic Solution
A study of the Streamline Surgical System versus competitor
Enrolling
Open Angle Glaucoma
Device: Streamline Surgical System
Device: iStent Inject W
The trial will evaluate the safety and efficacy of 3 dose regimens of H-1337 \[0.6% twice daily (b.i.d.), 1.0% b.i.d. and 1.0% once in the morning (q...
Active, not recruiting
Glaucoma Open-Angle Primary
Ocular Hypertension
Drug: Timolol 0.5%
Drug: H-1337 Placebo
Trial sponsors
S
S
D
F
N
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems